Shares of Sun Pharma, Aurobindo Pharma and other companies will remain in focus on Tuesday after US President Donald Trump-led administration included India on the list of 20 countries on whom it will not impose 100% tariff on some certain patented pharmaceutical imports and associated ingredients.
The US commerce department published the list, noting that it will not charge any ad valorem tariff on certain specialty drugs and associated ingredients used for treatment of rare medical conditions imported from these 20 countries, with India being one of them.
